Combination therapy with interferon-dexamethasone for newly diagnosed patients with multiple myeloma
โ Scribed by Meletios A. Dimopoulos; Donna Weber; Kay B. Delasalle; Raymond Alexanian
- Publisher
- John Wiley and Sons
- Year
- 1993
- Tongue
- English
- Weight
- 392 KB
- Volume
- 72
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
## BACKGROUND. Hepatocellular carcinoma (HCC) patients with major vascular involvement or extrahepatic metastasis are not good candidates for surgery or transarterial chemoembolization (TACE). In this study, the authors evaluated the efficacy of combined therapy with intraarterial cisplatin infusio
The bone marrow plasma cell labeling index (PCLI) as measured by bromodeoxyuridine uptake is a well-established independent prognostic factor for patients with newly diagnosed multiple myeloma, but the test is not easily done in most laboratories. The purpose of this study was to determine if the pr